Laddar...
Uncovering New Challenges in Targeting Glycolysis to Treat Th17 Cell-Mediated Autoimmunity
Targeting glycolysis in T helper 17 (Th17) cells presents an attractive opportunity to treat Th17 cell-mediated autoimmune diseases such as multiple sclerosis (MS). Pyruvate kinase isoform 2 (PKM2) is a glycolytic enzyme expressed in T cells infiltrating the central nervous system in a mouse model o...
Sparad:
| I publikationen: | Immunometabolism |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7894650/ https://ncbi.nlm.nih.gov/pubmed/33614166 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20900/immunometab20210006 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|